Heparan sulfate proteoglycan catabolic process

pathway activity — cross-omics
GO:0030200Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Heparan sulfate proteoglycan catabolic process pathway is significantly associated with the protein abundance of multiple proteins, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are LRMDA, BTK, and APOBR, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Heparan sulfate proteoglycan catabolic process activity versus LRMDA in GBM (Pearson r = 0.49).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMLRMDA →+0.620+0.083<.001<.00135
LSCCBTK →+0.508+0.053<.001.00235
GBMAPOBR →+0.540+0.079<.001<.00135
GBMARHGAP25_T443 →+0.466+0.045.002.00135
GBMPYCARD →+0.438+0.064<.001<.00135
COADRRBP1_T275 →-0.513-0.035.004<.00135
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0030200 vs LRMDA — GBM

Per-sample scatter of Heparan sulfate proteoglycan catabolic process activity vs LRMDA in GBM.

Explore this scatter interactively →

Exploration